Translational Cancer Research Program
Advancing cancer discoveries from the laboratory to clinical testing and patient care.
Overview
The Translational Cancer Research Program (TCRP) accelerates the path from small molecules and biologic modulators, optimization of delivery, and technology developments to clinical testing and subsequent clinical implementation. TCRP has fostered an interdisciplinary environment with expertise spanning drug development and clinical trial design and execution. TCRP activities are informed by strong integration with Community Outreach and Engagement (COE). COE provides Catchment Area (CA) data and community input to inform priorities.
Program Aims:
Aim1: Discover and develop molecules directed at cancer-relevant targets.
Investigators develop innovative approaches to identify, validate, and assess prospective cancer targets. They use genetic, pharmacological, chemical, and computational analyses to discover and develop assays, model systems, small molecules, and macromolecules involving validated targets, and optimize them for preclinical studies.
Aim2: Deliver small molecules and biologics with pre-clinical efficacy.
Investigators develop novel technologies for delivery of pharmaceutics and employ these to deliver small-molecule and macromolecule modulators, imaging agents, and RNAi that disrupt cancer cell signaling and/or for intraoperative tumor imaging to serve as leads for translation. Preclinical studies of the NCEs build the foundation for eventual clinical trial evaluation.
Aim3: Translate science to patients.
Clinician-scientists across medical, surgical, and radiation oncology drive clinical translation of novel targets, therapeutics, imaging agents, biologics, and delivery platforms and lead protocol development, regulatory strategy, and trial implementation. Reverse translation uses electronic health records, pharmacogenomics, biospecimens, and Investigator Initiated Trials to uncover resistance mechanisms, refine patient selection, and improve laboratory models.
Translational Cancer Research Program Member Directory
Find the complete list of Translational Cancer Research Program members in the Member Directory, and learn about their research.

